Calliditas reveals results from vital NefIgArd study
The study concerns the use of Nefecon among adult patients with primary IgA nephropathy
Read More
Tag: results
AstraZeneca’s Tagrisso delivers positive results
Company’s phase 3 study showed treatment with Tagrisso reduced risk of death by over half
Read More
Positive results from hVIVO study of Cidara flu candidate
Study demonstrated a reduction in viral replication in the upper respiratory tract as well as influenza infection
Read More
Evgen reveals results from pivotal phase 1b trial
Study involves SFX-01 candidate and emerging preliminary pharmacokinetic data from study
Read More
Sequana Medical announces positive results for DSR 2.0 candidate
Extensive phase 1 clinical trial evaluates safety of treatment among peritoneal patients
Read More
Positive results for Cerevance’s Parkinson’s drug
In phase 2 trials, the drug reduced ‘OFF time’ which refers to periods of the day when Parkinson’s symptoms recur despite medication
Read More
GSK sees dip in second-quarter sales
Sales decline in the second quarter reflects expected disruption from COVID-19
Read More
Tecentriq, Avastin combo trumps Nexavar in liver cancer
Hepatocellular carcinoma is a major cause of cancer deaths worldwide, affecting over 750,000 people every year.
Read More
Positive results for Novo’s Xultophy
The insulin degludec and liraglutide combination helps patients achieve blood glucose targets.
Read More
GSK reports Q1 sales decline
GlaxoSmithKline has booked a 2 percent dip in revenues for the first quarter to £7.2 billion, after results were hit by a “significant currency impact” and lower sales of prescription drugs.
Read More
GSK happy with 3 percent rise in 2017 sales
GlaxoSmithKline has reported a sales hike of 3 percent at constant exchange rates (CER*) for 2017, after growth was recorded across all of its three global businesses.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
